HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy.

BACKGROUND:The clinical significance and cellular sources of residual human immunodeficiency virus type 1 (HIV-1) production despite suppressive combination antiretroviral therapy (cART) remain unclear and the effect of low-level viremia on T-cell homeostasis is still debated. METHODOLOGY/PRINCIPAL...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Maud Mavigner, Pierre Delobel, Michelle Cazabat, Martine Dubois, Fatima-Ezzahra L'faqihi-Olive, Stéphanie Raymond, Christophe Pasquier, Bruno Marchou, Patrice Massip, Jacques Izopet
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Public Library of Science (PLoS) 2009-10-01
Edice:	PLoS ONE
On-line přístup:	http://europepmc.org/articles/PMC2765414?pdf=render
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!